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The chimeric anti-CD-20 antibody, rituximab is among standard treatment regimes in treating B-cell Non-
Hodgkin’s lymphoma. The possibility of conjugation and subsequent radiolabeling with beta (gamma) - 
emmiting radioisotopes can provide an added value to this therapeutical, thus increasing the possibility of 
targeted action to mature, malignant B-cells. Furthermore, designing a “ready to label”, freeze-dried 
immunoconjugate holds much advantages both in preserving the antibody stability and in the preparation and 
labeling with radioisotopes.  
Design of freeze-dried immunoconjugate kit was the main aim of this work, specifically in decision whether to 
add or not a cryoprotective and bulking agent, mannitol. For this purpose, rituximab, previously conjugated with 
three different bifunctional chelating agents, p-SCN-Bn-DOTA, p-SCN-Bn-DTPA and 1B4M-DTPA, adjusted 
to concentration of 1 mg/mL in 0.1M PBS (pH=8.0), with and without 10 mg/mL mannitol was freeze-dried, 
using Labconco Free Zone Stoppering Tray Dryer (USA). The immunoconjugate was gradually frozen, from 
5°C to -40 °C, at a rate of 0.40 °C/min, with retention time (RT) 3 h, followed by annealing step at -15 °C with 
RT of 6 h and again cooling to -40 °C with RT of two hours. The primary drying was conducted at -10 °C, with 
heating rate of 0.15 °C/min, and a RT of 25 hours, and the secondary drying at a temperature of 25 °C, with a 
heating rate of 0.15 °C/min, and RT of 11 hours. The freeze-dried samples were reconstituted with 0.9% NaCl, 
separated in Sephadex G25 column and resulted fractions analysed for absorbance at 280nm, using UV 
spectrophotometer (Jenway UV/VIS spectrophotometer 6715). The results, given as chromatographic profile of 
eluted fractions at 280nm, revealed no significant difference in profiles of samples containing mannitol vs. 
samples that did not contain mannitol. This result gave us the basis for further experiments in assessing long- 
term stability and optimizing radiolabeling experiments with the samples without mannitol in formulation. 
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